Allen Mooney & Barnes Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.78M Sell
4,815
-727
-13% -$743K 0.88% 40
2026
Q1
$5.1M Sell
5,542
-213
-4% -$216K 0.73% 43
2025
Q4
$6.18M Buy
5,755
+633
+12% +$605K 0.93% 38
2025
Q3
$3.91M Sell
5,122
-156
-3% -$116K 0.61% 42
2025
Q2
$4.11M Sell
5,278
-58
-1% -$45.1K 0.68% 40
2025
Q1
$4.41M Buy
5,336
+88
+2% +$73.2K 0.72% 41
2024
Q4
$4.05M Buy
5,248
+127
+2% +$105K 0.68% 42
2024
Q3
$4.54M Buy
5,121
+117
+2% +$105K 0.77% 40
2024
Q2
$4.53M Sell
5,004
-566
-10% -$453K 0.81% 40
2024
Q1
$4.23M Sell
5,570
-479
-8% -$341K 0.81% 38
2023
Q4
$3.53M Sell
6,049
-60
-1% -$35K 0.67% 40
2023
Q3
$3.28M Buy
6,109
+2
+0% +$1.03K 0.7% 39
2023
Q2
$2.86M Buy
6,107
+396
+7% +$166K 0.63% 39
2023
Q1
$1.96M Sell
5,711
-220
-4% -$74.2K 0.47% 52
2022
Q4
$2.17M Buy
5,931
+2
+0% +$709 0.52% 50
2022
Q3
$1.92M Buy
5,929
+1
+0% +$317 0.51% 50
2022
Q2
$1.92M Buy
5,928
+3
+0.1% +$901 0.49% 50
2022
Q1
$1.7M Buy
+5,925
New +$1.52M 0.38% 58

Other funds holding LLY

Allen Mooney & Barnes Investment Advisors's LLY Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $743K and leaving 4,815 shares worth $5.78M. The position accounts for 0.88% of the portfolio, ranked #40.

Allen Mooney & Barnes Investment Advisors first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.18M in Q4 2025. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 4,815 shares of Eli Lilly worth $5.78M as of Q2 2026.
  • Allen Mooney & Barnes Investment Advisors sold 727 Eli Lilly shares in Q2 2026, an estimated $743K.
  • Eli Lilly made up 0.88% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • Allen Mooney & Barnes Investment Advisors's Eli Lilly position peaked at $6.18M in Q4 2025.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.